| 123I-mIBG | 123I-meta-iodobenzylguanidine |
| ACE-I | angiotensin-converting enzyme inhibitors |
| ACS | acute coronary syndrome |
| ARB | angiotensin receptor blockers |
| ARNI | angiotensin-receptor neprilysine-inhibitor |
| BNP | brain natriuretic peptide |
| β-AR | β-adrenergic receptors |
| CHF | chronic heart failure |
| CZT | Cadmium–Zinc–Telluride |
| FBBG | Flubrobenguane |
| ICD | implantable cardioverter defibrillator |
| HED | hydroxyephedrine |
| HFPEF | heart failure with preserved ejection fraction |
| HFREF | heart failure with reduced ejection fraction |
| HRV | heart rate variability |
| H/M | heart-to-mediastinum ratio |
| LBBB | left bundle branch block |
| LVEF | left ventricular ejection fraction |
| LVESV | left ventricular end systolic volume |
| MAO | monoamine oxidase |
| MPI | myocardial perfusion imaging |
| NE | norepinephrine |
| NET | norepinephrine transporter |
| NYHA | New York heart association |
| OMT | optimal medical therapy |
| ROI | region-of-interest |
| SCD | sudden cardiac death |
| SDS | summed defect score |
| SGLT2 inhibitor | sodium-glucose cotransporter-2 inhibitor |
| SPECT | single-photon emission tomography |
| TCM | takotsubo cardiomyopathy |
| WO | washout |